These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 17134822)

  • 41. The gene encoding the prostatic tumor suppressor PSP94 is a target for repression by the Polycomb group protein EZH2.
    Beke L; Nuytten M; Van Eynde A; Beullens M; Bollen M
    Oncogene; 2007 Jul; 26(31):4590-5. PubMed ID: 17237810
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RING1 is associated with the polycomb group protein complex and acts as a transcriptional repressor.
    Satijn DP; Gunster MJ; van der Vlag J; Hamer KM; Schul W; Alkema MJ; Saurin AJ; Freemont PS; van Driel R; Otte AP
    Mol Cell Biol; 1997 Jul; 17(7):4105-13. PubMed ID: 9199346
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HPC3 is a new human polycomb orthologue that interacts and associates with RING1 and Bmi1 and has transcriptional repression properties.
    Bárdos JI; Saurin AJ; Tissot C; Duprez E; Freemont PS
    J Biol Chem; 2000 Sep; 275(37):28785-92. PubMed ID: 10825164
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polycomb repressor complex-2 is a novel target for mesothelioma therapy.
    Kemp CD; Rao M; Xi S; Inchauste S; Mani H; Fetsch P; Filie A; Zhang M; Hong JA; Walker RL; Zhu YJ; Ripley RT; Mathur A; Liu F; Yang M; Meltzer PA; Marquez VE; De Rienzo A; Bueno R; Schrump DS
    Clin Cancer Res; 2012 Jan; 18(1):77-90. PubMed ID: 22028491
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histopathological variables and biomarkers enhancer of zeste homologue 2, Ki-67 and minichromosome maintenance protein 7 as prognosticators in primarily endocrine-treated prostate cancer.
    Tolonen TT; Tammela TL; Kujala PM; Tuominen VJ; Isola JJ; Visakorpi T
    BJU Int; 2011 Nov; 108(9):1430-8. PubMed ID: 21592298
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epithelial-mesenchymal transition and cancer stemness: the Twist1-Bmi1 connection.
    Wu KJ; Yang MH
    Biosci Rep; 2011 Dec; 31(6):449-55. PubMed ID: 21919891
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Coexpression of BMI-1 and EZH2 polycomb group genes in Reed-Sternberg cells of Hodgkin's disease.
    Raaphorst FM; van Kemenade FJ; Blokzijl T; Fieret E; Hamer KM; Satijn DP; Otte AP; Meijer CJ
    Am J Pathol; 2000 Sep; 157(3):709-15. PubMed ID: 10980109
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validation of stem cell markers in clinical prostate cancer: α6-integrin is predictive for non-aggressive disease.
    Hoogland AM; Verhoef EI; Roobol MJ; Schröder FH; Wildhagen MF; van der Kwast TH; Jenster G; van Leenders GJ
    Prostate; 2014 May; 74(5):488-96. PubMed ID: 24375374
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new transgenic mouse model for conditional overexpression of the Polycomb Group protein EZH2.
    Koppens MA; Tanger E; Nacerddine K; Westerman B; Song JY; van Lohuizen M
    Transgenic Res; 2017 Apr; 26(2):187-196. PubMed ID: 27807665
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation.
    Kuzmichev A; Margueron R; Vaquero A; Preissner TS; Scher M; Kirmizis A; Ouyang X; Brockdorff N; Abate-Shen C; Farnham P; Reinberg D
    Proc Natl Acad Sci U S A; 2005 Feb; 102(6):1859-64. PubMed ID: 15684044
    [TBL] [Abstract][Full Text] [Related]  

  • 51. EZH2, Ki-67 and MCM7 are prognostic markers in prostatectomy treated patients.
    Laitinen S; Martikainen PM; Tolonen T; Isola J; Tammela TL; Visakorpi T
    Int J Cancer; 2008 Feb; 122(3):595-602. PubMed ID: 17943722
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Importance of Ezh2 polycomb protein in tumorigenesis process interfering with the pathway of growth suppressive key elements.
    Tonini T; D'Andrilli G; Fucito A; Gaspa L; Bagella L
    J Cell Physiol; 2008 Feb; 214(2):295-300. PubMed ID: 17786943
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic polymorphisms in the polycomb group gene EZH2 and the risk of lung cancer.
    Yoon KA; Gil HJ; Han J; Park J; Lee JS
    J Thorac Oncol; 2010 Jan; 5(1):10-6. PubMed ID: 19901851
    [TBL] [Abstract][Full Text] [Related]  

  • 54. pRB family proteins are required for H3K27 trimethylation and Polycomb repression complexes binding to and silencing p16INK4alpha tumor suppressor gene.
    Kotake Y; Cao R; Viatour P; Sage J; Zhang Y; Xiong Y
    Genes Dev; 2007 Jan; 21(1):49-54. PubMed ID: 17210787
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional antagonism of the Polycomb-Group genes eed and Bmi1 in hemopoietic cell proliferation.
    Lessard J; Schumacher A; Thorsteinsdottir U; van Lohuizen M; Magnuson T; Sauvageau G
    Genes Dev; 1999 Oct; 13(20):2691-703. PubMed ID: 10541555
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combined aberrant expression of Bmi1 and EZH2 is predictive of poor prognosis in glioma patients.
    Wu Z; Wang Q; Wang L; Li G; Liu H; Fan F; Li Z; Li Y; Tu Y
    J Neurol Sci; 2013 Dec; 335(1-2):191-6. PubMed ID: 24139839
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression analysis of putative stem cell markers in human benign and malignant prostate.
    Ugolkov AV; Eisengart LJ; Luan C; Yang XJ
    Prostate; 2011 Jan; 71(1):18-25. PubMed ID: 20583131
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of enhancer of zeste homolog 2 expression in peripheral circulating tumor cells in metastatic prostate cancer patients: a preliminary study.
    Cho KS; Oh HY; Lee EJ; Hong SJ
    Yonsei Med J; 2007 Dec; 48(6):1009-14. PubMed ID: 18159594
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MiR-203 Interplays with Polycomb Repressive Complexes to Regulate the Proliferation of Neural Stem/Progenitor Cells.
    Liu PP; Tang GB; Xu YJ; Zeng YQ; Zhang SF; Du HZ; Teng ZQ; Liu CM
    Stem Cell Reports; 2017 Jul; 9(1):190-202. PubMed ID: 28602614
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Akt-mediated phosphorylation of Bmi1 modulates its oncogenic potential, E3 ligase activity, and DNA damage repair activity in mouse prostate cancer.
    Nacerddine K; Beaudry JB; Ginjala V; Westerman B; Mattiroli F; Song JY; van der Poel H; Ponz OB; Pritchard C; Cornelissen-Steijger P; Zevenhoven J; Tanger E; Sixma TK; Ganesan S; van Lohuizen M
    J Clin Invest; 2012 May; 122(5):1920-32. PubMed ID: 22505453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.